Maravai LifeSciences Holdings, Inc. MRVI Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $165.92M-41.8% | $216.89M-32.7% | $243.57M-57.9% | $269.91M-52.9% | $285.05M-49.3% | ||
| $33.42M+17.3% | $25.5M-33.8% | $22.54M-21.7% | $27.88M-19.7% | $28.49M-22.3% | ||
| $40.46M-18.7% | $40.5M-19.1% | $45.33M-10.3% | $46.67M-5.4% | $49.77M-0.1% | ||
| $12.85M-25.3% | $14.61M-14.0% | $16.03M-3.8% | $16.43M-5.9% | $17.21M+0.8% | ||
| $8.98M-9.4% | $7.32M-27.2% | $9.7M-9.7% | $10.52M-4.6% | $9.92M-20.8% | ||
| $18.63M-17.7% | $18.57M-19.5% | $19.59M-14.8% | $19.72M-5.3% | $22.65M+11.9% | ||
| $11.94M-7.9% | $13.37M-26.3% | $14.43M-33.4% | $15.31M-10.3% | $12.96M-22.9% | ||
| $251.74M-33.1% | $296.25M-31.0% | $325.87M-52.0% | $359.76M-47.2% | $376.28M-43.7% | ||
| $146.93M-11.7% | $151.48M-7.9% | $158.62M-3.6% | $162.73M-1.7% | $166.43M+3.0% | ||
| $129.43M-19.0% | $129.43M-19.0% | $129.43M-24.7% | $129.43M-60.3% | $159.88M-51.0% | ||
| $144.89M-27.4% | $151.54M-22.3% | $185.88M-7.9% | $193.07M-6.8% | $199.58M-6.8% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $713.22M-25.7% | $770.58M-23.6% | $849.19M-33.6% | $896.97M-37.9% | $959.75M-33.6% | ||
| $8.54M-10.4% | $2.91M-75.7% | $8M+430% | $11.53M+152% | $9.53M+359% | ||
| $28.65M-35.8% | $36.57M-7.6% | $12.55M-67.7% | $16.44M-59.6% | $44.6M+353% | ||
| $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | ||
| $3.2M-8.6% | $3M-9.1% | $2.6M-10.3% | $2.6M-25.7% | $3.5M-16.7% | ||
| $42.62M-32.5% | $44.92M-21.2% | $61.57M-3.4% | $69.68M+1.5% | $63.16M+7.0% | ||
| $235.57M-18.6% | $286.33M-1.4% | $287.38M-44.3% | $288.44M-44.2% | $289.5M-44.1% | ||
| $29.87M-3.3% | $30.14M-3.1% | $30.41M-2.9% | $30.65M-2.8% | $30.88M-2.6% | ||
| $36.07M-18.0% | $36.48M-30.5% | $37.97M-30.0% | $38.19M-29.3% | $43.97M-25.0% | ||
| $344.13M-19.9% | $397.87M-7.7% | $417.33M-37.3% | $428.98M-36.1% | $429.48M-35.6% | ||
| $202.13M+8.2% | $199.18M+9.5% | $196.51M+11.9% | $191.38M+13.7% | $186.8M+38.9% | ||
| $6.39M-94.2% | $10.12M-92.8% | $45.8M-72.5% | $71.36M-73.0% | $110.95M-59.5% | ||
| $466K+43.8% | $524K— | $579K— | $574K— | $324K— | ||
| $157.52M-31.4% | $160.33M-36.4% | $186.42M-30.4% | $202.12M-40.2% | $229.66M-37.4% | ||
| $211.56M-29.6% | $212.38M-34.7% | $245.44M-28.8% | $265.86M-38.8% | $300.61M-26.8% | ||
| $713.22M-25.7% | $770.58M-23.6% | $849.19M-33.6% | $896.97M-37.9% | $959.75M-33.6% | ||
| $18.63M-17.7% | $18.57M-19.5% | $19.59M-14.8% | $19.72M-5.3% | $22.65M+11.9% | ||
| $1.3M-23.5% | —— | $1.5M+87.5% | $1.6M+60.0% | $1.7M+41.7% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $144.89M-27.4% | $151.54M-22.3% | $185.88M-7.9% | $193.07M-6.8% | $199.58M-6.8% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $146.93M-11.7% | $151.48M-7.9% | $158.62M-3.6% | $162.73M-1.7% | $166.43M+3.0% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $28.65M-35.8% | $36.57M-7.6% | $48.14M+23.7% | $50.2M+23.3% | $44.6M+26.0% | ||
| $28.65M-35.8% | $36.57M-7.6% | $48.14M+23.7% | $50.2M+23.3% | $44.6M+26.0% | ||
| $4.08M0.0% | —— | $1.36M0.0% | $2.72M0.0% | $4.08M0.0% | ||
| $1.3M-23.5% | —— | $1.5M+87.5% | $1.6M+60.0% | $1.7M+41.7% | ||
| $1.87M-44.7% | $2.47M-34.1% | $2.78M-62.0% | $3.08M-60.8% | $3.38M-59.9% | ||
| $270.88M-17.1% | $364.71M-3.2% | $367.94M-34.4% | $371.08M-34.0% | $326.65M-41.9% | ||
| $242.88M-18.6% | —— | $295.6M-44.1% | $296.96M-44.0% | $298.32M-43.9% | ||
| $1.1M-66.7% | $1M-72.2% | $400K-88.2% | $400K— | $3.3M— | ||
| 6.3M— | —— | 3.3M— | 3.3M— | 0— | ||
| $0— | $0— | —— | —— | —— | ||
| $3.2M-8.6% | $3M-9.1% | $2.6M-10.3% | $2.6M-25.7% | $3.5M-16.7% | ||
| $242.88M-18.6% | —— | $295.6M-44.1% | $296.96M-44.0% | $298.32M-43.9% | ||
| $238.8M+4,290% | —— | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | ||
| $4.08M0.0% | —— | $1.36M0.0% | $2.72M0.0% | $4.08M0.0% | ||
| $157.52M-31.4% | $160.33M-36.4% | $186.42M-30.4% | $202.12M-40.2% | $229.66M-37.4% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $1.1M-66.7% | $1M-72.2% | $400K-88.2% | $400K— | $3.3M— | ||
| $4.5M+463% | —— | $600K-73.0% | $900K-55.0% | $800K-77.8% | ||
| $4.1M— | —— | —— | —— | —— | ||
| $4.08M0.0% | —— | $1.36M0.0% | $2.72M0.0% | $4.08M0.0% | ||
| $4.5M+463% | —— | $600K+1.7% | $900K-55.0% | $800K-77.8% | ||
| $400K— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Maravai LifeSciences Holdings, Inc.'s total assets?
- Maravai LifeSciences Holdings, Inc. (MRVI) holds $713.2M in total assets, down 25.7% year over year.
- How much debt does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. carries $270.9M in total debt against $211.6M of shareholders' equity, a debt-to-equity ratio of 1.28.
- How much cash does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. holds $165.9M in cash and equivalents.
- Can Maravai LifeSciences Holdings, Inc. cover its short-term obligations?
- Its current ratio is 5.91 — current assets exceed current liabilities.
- Where does Maravai LifeSciences Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
